BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15176058)

  • 1. Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone.
    Leitner VM; Guggi D; Bernkop-Schnürch A
    J Pharm Sci; 2004 Jul; 93(7):1682-91. PubMed ID: 15176058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system.
    Leitner VM; Guggi D; Krauland AH; Bernkop-Schnürch A
    J Control Release; 2004 Nov; 100(1):87-95. PubMed ID: 15491813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides.
    Vetter A; Martien R; Bernkop-Schnürch A
    J Pharm Sci; 2010 Mar; 99(3):1427-39. PubMed ID: 19708062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
    Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
    Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin.
    Bernkop-Schnürch A; Obermair K; Greimel A; Palmberger TF
    Amino Acids; 2006 Jun; 30(4):417-23. PubMed ID: 16554973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glutathione in the permeation enhancing effect of thiolated polymers.
    Clausen AE; Kast CE; Bernkop-Schnürch A
    Pharm Res; 2002 May; 19(5):602-8. PubMed ID: 12069161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.
    Kast CE; Guggi D; Langoth N; Bernkop-Schnürch A
    Pharm Res; 2003 Jun; 20(6):931-6. PubMed ID: 12817900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil.
    Clausen AE; Bernkop-Schnürch A
    J Pharm Sci; 2000 Oct; 89(10):1253-61. PubMed ID: 10980500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oral oligonucleotide delivery system based on a thiolated polymer: Development and in vitro evaluation.
    Martien R; Hoyer H; Perera G; Schnürch AB
    Eur J Pharm Biopharm; 2011 Aug; 78(3):355-60. PubMed ID: 21295141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system.
    Vetter A; Bernkop-Schnürch A
    J Drug Target; 2010 May; 18(4):303-12. PubMed ID: 19947818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of thiolated poly(acrylic acid) microparticles for the nasal administration of exenatide.
    Millotti G; Vetter A; Leithner K; Sarti F; Shahnaz Bano G; Augustijns P; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1677-82. PubMed ID: 24131355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroretentive particles formulated with thiomers: development and in vitro evaluation.
    Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
    J Drug Target; 2010 Jun; 18(5):362-72. PubMed ID: 20021230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits.
    Hornof MD; Bernkop-Schnürch A
    J Pharm Sci; 2002 Dec; 91(12):2588-92. PubMed ID: 12434402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiomers: Impact of in situ cross-linkers on mucoadhesive properties.
    Lam HT; Leonaviciute G; Zupančič O; Bernkop-Schnürch A
    Eur J Pharm Sci; 2017 Aug; 106():41-48. PubMed ID: 28549680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system.
    Krauland AH; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):181-7. PubMed ID: 15018973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport characteristics of a beta sheet breaker peptide across excised bovine nasal mucosa.
    Greimel A; Bernkop-Schnürch A; Del Curto MD; D'Antonio M
    Drug Dev Ind Pharm; 2007 Jan; 33(1):71-7. PubMed ID: 17192253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vivo evaluation of an oral drug delivery system for paclitaxel.
    Iqbal J; Sarti F; Perera G; Bernkop-Schnürch A
    Biomaterials; 2011 Jan; 32(1):170-5. PubMed ID: 20926128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy.
    Carvalho FC; Campos ML; Peccinini RG; Gremião MP
    Eur J Pharm Biopharm; 2013 May; 84(1):219-27. PubMed ID: 23207328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(acrylic acid)-cysteine for oral vitamin B12 delivery.
    Sarti F; Iqbal J; Müller C; Shahnaz G; Rahmat D; Bernkop-Schnürch A
    Anal Biochem; 2012 Jan; 420(1):13-9. PubMed ID: 21964499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.